Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.
about
Role of mesenchymal cells in the natural history of ovarian cancer: a reviewGlioblastoma Circulating Cells: Reality, Trap or Illusion?Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approachMetastatic mechanisms in follicular cell-derived thyroid cancerLife history trade-offs in cancer evolutionOptimized staining and proliferation modeling methods for cell division monitoring using cell tracking dyesMeta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancerBlockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cellsMirk/dyrk1B kinase is upregulated following inhibition of mTOR.Dual-factor triggered fluorogenic nanoprobe for ultrahigh contrast and subdiffraction fluorescence imaging.4EGI-1 targets breast cancer stem cells by selective inhibition of translation that persists in CSC maintenance, proliferation and metastasisA cellular automaton model for tumor dormancy: emergence of a proliferative switch.Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.Contribution of TIP30 to chemoresistance in laryngeal carcinoma.Epithelial-mesenchymal transition stimulates human cancer cells to extend microtubule-based invasive protrusions and suppresses cell growth in collagen gel.Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.Tracking immune cell proliferation and cytotoxic potential using flow cytometry.Ovarian cancer stem cell markers: prognostic and therapeutic implications.Combination Treatment with All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung CancerNovel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactionsIn vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase.Hes1: a key role in stemness, metastasis and multidrug resistance.Role of the microenvironment in ovarian cancer stem cell maintenance.FOXA1 expression affects the proliferation activity of luminal breast cancer stem cell populations.Role of connexins in metastatic breast cancer and melanoma brain colonizationElucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsetsHitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche.Strategies for isolating and enriching cancer stem cells: well begun is half doneGeneration of cancer stem-like cells through the formation of polyploid giant cancer cells.Stem cell expansion during carcinogenesis in stem cell-depleted conditional telomeric repeat factor 2 null mutant mice.New insights into the troubles of aneuploidyOvarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.Ovarian cancer stem cells: still an elusive entity?Stem Cell Differentiation Stage Factors from Zebrafish Embryo: A Novel Strategy to Modulate the Fate of Normal and Pathological Human (Stem) CellsCancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy.Cancer stem cells and their potential implications for the treatment of solid tumors.Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.
P2860
Q26823555-135AF227-BD92-44A1-A13C-BB2ACBDBC67DQ26823823-CD91D9A4-190E-4EA3-B684-E6958C25082BQ26849477-4334BB7F-CE6C-43D1-90B3-FACABF4B96EEQ27005646-33A23ACB-53D6-42ED-AA08-0BA445B6B700Q28657962-8865BC55-902E-4103-BB58-7508E77F71D2Q28681906-6F0C4AEE-F2DA-43BD-8691-5F7808C73932Q33555064-CAD91405-D1FF-420C-871E-34E76959FDB2Q33702231-F17B109B-71A9-4308-BA58-50B4554B8A96Q34096774-33D64FDA-07E3-40A0-9E2C-013DD943022EQ34205394-E876924B-912F-47B6-882C-F87049D97788Q34227573-2159E692-F68C-4AFB-AB61-1121368E3A30Q34351959-42C131C4-7F33-4C9A-BB5F-2622FE0ED188Q34353023-ACE9DA32-8D81-4838-97F3-6AC9627FA22CQ34476278-57EA4C18-4AFF-4E9E-9B3B-6929194629A8Q34541595-681FD2C2-AB5E-4ACF-903B-281D9DD6B769Q34541763-CE0B7193-A6E8-48B8-9934-34B433716F52Q34975148-E9E6FBB2-4723-4EE2-874F-2D6A4DD6CA24Q35212162-4C0447C9-6B71-4EE5-9667-59F59607CCD0Q35606242-E5E484C8-E66E-4A50-AB55-CFCB8CBC7CE1Q35744111-957FAA6A-FA63-433A-902D-D735EC1DFD19Q35749822-D5CBD9F3-81CC-4543-BEF1-F3DD193A7C68Q36176245-D16946E8-B6D5-41A2-9483-FDED6E7192BCQ36213706-085EB117-6818-492A-8C92-20F23C5BC8F7Q36665179-6E2E1BDC-00DE-493B-AB07-FFC625426468Q36746291-7C95F4A5-9BF4-472C-B0B6-3A9B78ACC6FFQ36764121-44779B9C-BAB4-4984-A269-25A96552C594Q36860276-500441E1-8E23-42CC-8811-EF809A121D1BQ36916624-47496DFC-20F2-4C4F-BA12-081E287085B0Q37061915-263A5096-6101-4F79-B9EE-C99D591D4F59Q37351339-043D620C-5227-4DB0-B49F-3A09A2B0CB23Q37543432-FFC8C1EE-E362-4446-A162-A5F8922E8857Q37574324-B7F00522-E96D-45BE-A235-5557E75FF7BEQ37589137-E96AECBF-9B20-4DEF-AC9E-A275934BA93CQ37615918-499FF293-FDCF-4FD9-9424-AA611AD74AE8Q37713683-97046B98-FE69-47CD-B68D-2C8AA028CF27Q37741546-41AA9880-9AA8-4649-A5EF-BB3005D33DB9Q37885165-0206271D-9E9B-462B-99D6-6F75D963E74FQ37906461-2A556983-F565-4260-BB70-9832F619C87FQ37988791-E4415A0E-EDD3-4ADA-BD5C-E46D943E4F1AQ37991971-82911C37-A3D0-4055-9AB2-2A0589F45321
P2860
Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@en
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@nl
type
label
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@en
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@nl
prefLabel
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@en
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@nl
P1433
P1476
Cancer stem cells and aneuploi ...... eterminants of tumor dormancy.
@en
P2093
Anjali P Kusumbe
Sharmila A Bapat
P304
P356
10.1158/0008-5472.CAN-09-2802
P407
P577
2009-12-01T00:00:00Z